Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1990 1
1991 4
1992 3
1993 3
1994 2
1995 2
1996 2
1997 3
1998 2
2004 2
2006 3
2007 2
2008 4
2009 3
2010 5
2011 3
2013 1
2014 3
2015 2
2016 2
2017 1
2019 2
2020 2
2021 2
2022 2
2024 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial.
Cortes J, Cescon DW, Rugo HS, Nowecki Z, Im SA, Yusof MM, Gallardo C, Lipatov O, Barrios CH, Holgado E, Iwata H, Masuda N, Otero MT, Gokmen E, Loi S, Guo Z, Zhao J, Aktan G, Karantza V, Schmid P; KEYNOTE-355 Investigators. Cortes J, et al. Lancet. 2020 Dec 5;396(10265):1817-1828. doi: 10.1016/S0140-6736(20)32531-9. Lancet. 2020. PMID: 33278935 Clinical Trial.
Rehabilitation post pulmonary embolism: Preliminary data.
Azzarito M, Fabiano C, Bellini R, Ruzzolini M. Azzarito M, et al. Among authors: fabiano c. Int J Cardiol Cardiovasc Risk Prev. 2024 Apr 29;21:200269. doi: 10.1016/j.ijcrp.2024.200269. eCollection 2024 Jun. Int J Cardiol Cardiovasc Risk Prev. 2024. PMID: 39118981 Free PMC article. Review. No abstract available.
A homozygous MED11 C-terminal variant causes a lethal neurodegenerative disease.
Calì E, Lin SJ, Rocca C, Sahin Y, Al Shamsi A, El Chehadeh S, Chaabouni M, Mankad K, Galanaki E, Efthymiou S, Sudhakar S, Athanasiou-Fragkouli A, Çelik T, Narlı N, Bianca S, Murphy D, De Carvalho Moreira FM; SYNaPS Study Group; Andrea Accogli, Petree C, Huang K, Monastiri K, Edizadeh M, Nardello R, Ognibene M, De Marco P, Ruggieri M, Zara F, Striano P, Şahin Y, Al-Gazali L, Abi Warde MT, Gerard B, Zifarelli G, Beetz C, Fortuna S, Soler M, Valente EM, Varshney G, Maroofian R, Salpietro V, Houlden H. Calì E, et al. Genet Med. 2022 Oct;24(10):2194-2203. doi: 10.1016/j.gim.2022.07.013. Epub 2022 Aug 24. Genet Med. 2022. PMID: 36001086 Free PMC article.
Hepatitis C virus replication in 'autoimmune' chronic hepatitis.
Magrin S, Craxi A, Fabiano C, Fiorentino G, Almasio P, Palazzo U, Pinzello G, Provenzano G, Pagliaro L, Choo QL, et al. Magrin S, et al. Among authors: fabiano c. J Hepatol. 1991 Nov;13(3):364-7. doi: 10.1016/0168-8278(91)90082-m. J Hepatol. 1991. PMID: 1725529
Long-term course of interferon-treated chronic hepatitis C.
Cammà C, Di Marco V, Lo Iacono O, Almasio P, Giunta M, Fuschi P, Vaccaro A, Fabiano C, Magrin S, Di Stefano R, Bonura C, Pagliaro L, Craxì A. Cammà C, et al. Among authors: fabiano c. J Hepatol. 1998 Apr;28(4):531-7. doi: 10.1016/s0168-8278(98)80274-2. J Hepatol. 1998. PMID: 9566819 Clinical Trial.
60 results